The first comprehensive text on dyslipidemia from a major academic institution, this book covers all aspects of dyslipidemia as it relates to human disease, including coronary artery disease, cerebrovascular disease, peripheral vascular disease, and pancreatitis. The material is presented in a clinician-friendly format and includes references for additional reading. Reflecting current guidelines from the National Cholesterol Education Program, the book explains why, when, and how to treat dyslipidemia. Coverage includes dietary treatment, drug treatment, and recommendations for special populations such as patients with coronary heart disease, patients at high risk for coronary heart disease, patients with diabetes, women, older adults, young adults, and racial and ethnic groups.Caveats Regarding Combination Lipid-lowering Therapies Because most diabetic patients have a combined hyperlipidemia, ... Very high doses of niacin can cause worsening of glycemic control; however, most recent studies show that at modest doses of 750 to 2, 000 mg/day, glycemic control does not deteriorate significantly and is usually amenable to adjustments in glucose-lowering therapies (38, 47).
|Title||:||The Johns Hopkins Textbook of Dyslipidemia|
|Publisher||:||Lippincott Williams & Wilkins - 2010|